Cognition Therapeutics (CGTX) Non-cash Items (2020 - 2026)

Cognition Therapeutics (CGTX) has 7 years of Non-cash Items data on file, last reported at $3.9 million in Q1 2026.

• Quarterly Non-cash Items rose 19.01% year-over-year to $3.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $3.9 million (up 19.01% YoY) and the FY2025 annual result came in at $3.4 million, up 67.0% from the prior year.
• Non-cash Items advanced to $3.9 million in Q1 2026 per CGTX's latest filing, from $210000.0 in the prior quarter.
• Across five years, Non-cash Items topped out at $5.3 million in Q3 2023 and bottomed at $210000.0 in Q4 2025.
• The 5-year median for Non-cash Items is $2.8 million (2025), against an average of $2.8 million.
• The widest annual swing landed in 2023, when Non-cash Items jumped 145.22%; it then plunged 89.78% in 2025.
• Tracing CGTX's Non-cash Items over 5 years: stood at $2.1 million in 2022, then slipped by 24.27% to $1.6 million in 2023, then soared by 30.15% to $2.1 million in 2024, then sank by 89.78% to $210000.0 in 2025, then surged by 1739.52% to $3.9 million in 2026.
• Per Business Quant, the three latest CGTX Non-cash Items figures stand at $3.9 million (Q1 2026), $210000.0 (Q4 2025), and $2.0 million (Q3 2025).

Peer Comparison